Table 1 Prevalence of non-adherence to antidiabetic medications among patient with type 2 diabetes mellitus in Limbe and Bamenda Regional Hospitals, Cameroon, 2016
Variable | Adherent n (%) | Non-adherent n (%) | Total N (%) | p-value |
|---|---|---|---|---|
Overall, n (%) [95% CI] | 89 (45.6) [38.7–52.5] | 106 (54.4) [47.1–61.5] |  |  |
Age (in years) | ||||
 ≤ 60 | 37 (35.9) | 66 (64.1) | 103(52.8) | 0.01 |
 > 60 | 52 (56.5) | 40 (43.5) | 92 (47.2) | |
Educational level (n = 194) | ||||
 Never | 26 (66.7) | 13 (33.3) | 39 (20.1) | 0.03 |
 Primary | 35 (42.2) | 48 (57.8) | 83 (42.8) | |
 Secondary | 14 (35.9) | 25 (64.1) | 39 (20.1) | |
 High school/University | 13 (39.4) | 20 (60.6) | 33 (17.0) | |
Gender (n = 194) | ||||
 Male | 23 (39.7) | 35 (60.3) | 58 (29.9) | 0.30 |
 Female | 65 (47.5) | 71 (52.2) | 136 (70.1) | |
Co-morbidity** | ||||
 Hypertension (n = 121) | 58 (47.9) | 63 (52.1) | 121 (100) | 0.35 |
 Chronic renal disease (n = 7) | 2 (28.6) | 5 (71.4) | 7 (100) | 0.37* |
 Heart failure (n = 7) | 0 (0.0) | 7 (100) | 7 (100) | 0.01* |
 Stroke (n = 5) | 3 (60) | 2 (40) | 5 (100) | 0.51* |
Duration of diabetes (in years) [n = 192] | ||||
  < 5 years | 49 (51.6) | 46 (48.4) | 95 (49.5) | 0.07* |
 6–10 years | 14 (31.8) | 30 (68.2) | 44 (22.9) | |
 11–20 years | 17 (38.6) | 27 (61.4) | 44 (22.9) | |
  > 20 years | 6 (66.7) | 3 (33.3) | 9 (4.7) | |
Number of diabetic complications (n = 194) | ||||
 None | 40 (50.0) | 40 (50.0) | 80 (41.2) | 0.54 |
 1 | 35 (42.7) | 47 (57.3) | 82 (42.3) | |
 2 or more | 13 (40.6) | 19 (59.4) | 32 (16.5) | |
Alcohol consumption (n = 194) | ||||
 Yes | 26 (34.7) | 49 (65.3) | 75 (38.7) | 0.02 |
 No | 62 (52.1) | 57 (47.9) | 119 (61.3) | |
Tobacco use (n = 194) | ||||
 Yes | 1 (33.3) | 2 (66.7) | 3 (1.5) | 0.67* |
 No | 87 (45.5) | 104 (54.5) | 191 (98.5) | |
Current antidiabetic medications (n = 192) |  | |||
 Single OHA | 43 (53.8) | 37 (46.3) | 80 (41.7) | 0.06 |
 Two OHA | 26 (48.2) | 28 (51.8) | 54 (28.1) | |
 Insulin | 7 (26.9) | 19 (73.1) | 26 (13.5) | |
 Insulin and OHA | 11 (34.4) | 21 (65.6) | 32 (16.7) | |
Method of glycaemic control (n = 178) | ||||
 FBS | 82 (47.1) | 92 (52.9) | 174 (97.8) | 0.41* |
 Glycated haemoglobin | 0 (0.0) | 2 (100) | 2 (1.1) | |
 Both | 1 (50.0) | 1 (50.0) | 2 (1.1) | |
Hospital setting (n = 195) | ||||
 BRH | 46 (46.0) | 54 (54.0) | 100 (51.3) | 0.85 |
 LRH | 43 (45.3) | 52 (54.7) | 95 (48.7) | |